Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablation Vs. Radiofrequency Ablation: a Preliminary Randomized Controlled Study
1 other identifier
interventional
60
1 country
1
Brief Summary
Efficacy and safety of pulsed field ablation in refractory mitral isthmus-dependent atrial flutter: pulsed field ablation vs. radiofrequency ablation: a preliminary randomized controlled study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2025
CompletedStudy Start
First participant enrolled
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 27, 2025
February 1, 2025
9 months
February 24, 2025
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Achieve persistent mitral isthmus block
After mitral isthmus block, wait for 20 minutes, and obtain persistent MI block after the waiting period.
Immediate post-operative mitral isthmus block rate.
Secondary Outcomes (2)
Episodes of atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 seconds occurred.
During the 3-month post-operative follow-up.
The safety endpoint
During the 3-month post-operative follow-up.
Study Arms (2)
Radiofrequency ablation unit
ACTIVE COMPARATORThe patient underwent radiofrequency ablation treatment. After electrophysiological examination, radiofrequency ablation was performed.
The pulse field ablation group
EXPERIMENTALThe pulse field ablation group will undergo pulse field ablation of the mitral valve commissure.
Interventions
The pulse field ablation group will undergo pulse field ablation of the mitral valve commissure.
In the radiofrequency ablation group, patients will undergo radiofrequency ablation targeted at the mitral valve commissure.
Eligibility Criteria
You may qualify if:
- Patients aged ≥18 years. 2.Diagnosed with persistent symptomatic refractory mitral valve commissural-dependent atrial flutter. Refractory mitral valve commissural-dependent atrial tachycardia is defined as:
- Failure of drug therapy: At least one Class I or III antiarrhythmic drug (e.g., propafenone, amiodarone) fails to effectively control or prevent episodes.
- Failure of catheter ablation: At least one previous attempt at radiofrequency catheter ablation (RFCA) targeting the mitral valve commissure has been unsuccessful (either due to recurrence post-procedure or failure to achieve bidirectional block at the commissure).
- Intolerant to at least one antiarrhythmic drug (AAD). 4.The patient must be capable of and willing to provide written informed consent to participate in this study.
You may not qualify if:
- Pregnant or breastfeeding women.
- Presence of left atrial thrombus on preoperative imaging.
- Life expectancy less than 1 year.
- Coagulation disorders or contraindications to anticoagulant therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Chest Hospital
Shanghai, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 24, 2025
First Posted
February 27, 2025
Study Start
February 24, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share